IL6 and metabolic dysfunction-associated steatotic liver disease: Gao et al., in a case–control study that included 46 Chinese patients with NAFLD and 121 controls from early 2020, showed that patients with NAFLD had higher serum IL-6 levels that correlated with disease severity [15].